This is a phase 2a clinical trial performed to evaluate the efficacy of a topical treatment
of ibuprofen compared to the use of a placebo topical treatment.
A multi-center, double-blinded, randomized placebo controlled study. Study length: 14 days
Dosing twice daily (b.i.d.)